Progress in the diagnosis and treatment of urachal carcinoma

VernacularTitle:脐尿管癌诊断与治疗的研究进展
Author: Yushuang CUI ¹ ; Yudong CAO ; Shuo WANG ; Peng DU
Author Information

1. 北京大学肿瘤医院暨北京市肿瘤防治研究所泌尿外科　恶性肿瘤发病机制及转化研究教育部重点实验室，北京　100142
Keywords: Urachal carcinoma; Adenocarcinoma of bladder; Chemotherapy; Immunotherapy; Partial cystectomy
From: Chinese Journal of Urology 2024;45(9):722-724
CountryChina
Language:Chinese
Abstract: Urachal carcinoma (UrC)is a rare urological malignancy. UrC is not obvious in its early symptoms, and is mostly in the advanced stage at diagnosis, with a poor prognosis. Surgical treatment was preferred by partial cystectomy + resection of complete umbilical and umbilical urinary catheter ± pelvic lymph node dissection, and more than 90% of UrC were confirmed as adenocarcinoma through postoperative pathology. Systemic treatment is often based on treatment protocols for bladder adenocarcinoma or colorectal adenocarcinoma.This article reviews recent domestic and international research on UrC, summarizing its incidence, clinical characteristics, diagnosis, and treatment.